rs45598436

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_002227.4(JAK1):​c.579T>C​(p.Ala193Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0912 in 1,613,434 control chromosomes in the GnomAD database, including 7,752 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.078 ( 577 hom., cov: 32)
Exomes 𝑓: 0.093 ( 7175 hom. )

Consequence

JAK1
NM_002227.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: -1.07

Publications

13 publications found
Variant links:
Genes affected
JAK1 (HGNC:6190): (Janus kinase 1) This gene encodes a membrane protein that is a member of a class of protein-tyrosine kinases (PTK) characterized by the presence of a second phosphotransferase-related domain immediately N-terminal to the PTK domain. The encoded kinase phosphorylates STAT proteins (signal transducers and activators of transcription) and plays a key role in interferon-alpha/beta, interferon-gamma, and cytokine signal transduction. This gene plays a crucial role in effecting the expression of genes that mediate inflammation, epithelial remodeling, and metastatic cancer progression. This gene is a key component of the interleukin-6 (IL-6)/JAK1/STAT3 immune and inflammation response and is a therapeutic target for alleviating cytokine storms. The kinase activity of this gene is directly inhibited by the suppressor of cytokine signalling 1 (SOCS1) protein. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2020]
JAK1 Gene-Disease associations (from GenCC):
  • autoinflammation, immune dysregulation, and eosinophilia
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.82).
BP6
Variant 1-64869379-A-G is Benign according to our data. Variant chr1-64869379-A-G is described in ClinVar as Benign. ClinVar VariationId is 1168339.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.07 with no splicing effect.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.103 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_002227.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
NM_002227.4
MANE Select
c.579T>Cp.Ala193Ala
synonymous
Exon 6 of 25NP_002218.2P23458
JAK1
NM_001320923.2
c.579T>Cp.Ala193Ala
synonymous
Exon 7 of 26NP_001307852.1P23458
JAK1
NM_001321852.2
c.579T>Cp.Ala193Ala
synonymous
Exon 6 of 25NP_001308781.1P23458

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
JAK1
ENST00000342505.5
TSL:5 MANE Select
c.579T>Cp.Ala193Ala
synonymous
Exon 6 of 25ENSP00000343204.4P23458
JAK1
ENST00000671929.2
c.579T>Cp.Ala193Ala
synonymous
Exon 7 of 26ENSP00000500485.1P23458
JAK1
ENST00000671954.2
c.579T>Cp.Ala193Ala
synonymous
Exon 7 of 26ENSP00000500841.1P23458

Frequencies

GnomAD3 genomes
AF:
0.0776
AC:
11808
AN:
152086
Hom.:
577
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0378
Gnomad AMI
AF:
0.110
Gnomad AMR
AF:
0.0793
Gnomad ASJ
AF:
0.0948
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.0133
Gnomad FIN
AF:
0.113
Gnomad MID
AF:
0.0918
Gnomad NFE
AF:
0.105
Gnomad OTH
AF:
0.0860
GnomAD2 exomes
AF:
0.0775
AC:
19326
AN:
249384
AF XY:
0.0764
show subpopulations
Gnomad AFR exome
AF:
0.0391
Gnomad AMR exome
AF:
0.0543
Gnomad ASJ exome
AF:
0.0975
Gnomad EAS exome
AF:
0.0000556
Gnomad FIN exome
AF:
0.116
Gnomad NFE exome
AF:
0.109
Gnomad OTH exome
AF:
0.0958
GnomAD4 exome
AF:
0.0926
AC:
135296
AN:
1461230
Hom.:
7175
Cov.:
31
AF XY:
0.0910
AC XY:
66161
AN XY:
726944
show subpopulations
African (AFR)
AF:
0.0371
AC:
1241
AN:
33468
American (AMR)
AF:
0.0577
AC:
2579
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.0946
AC:
2472
AN:
26130
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39696
South Asian (SAS)
AF:
0.0146
AC:
1259
AN:
86254
European-Finnish (FIN)
AF:
0.112
AC:
5993
AN:
53402
Middle Eastern (MID)
AF:
0.0839
AC:
484
AN:
5766
European-Non Finnish (NFE)
AF:
0.105
AC:
116252
AN:
1111412
Other (OTH)
AF:
0.0830
AC:
5013
AN:
60382
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
5817
11633
17450
23266
29083
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4002
8004
12006
16008
20010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0775
AC:
11803
AN:
152204
Hom.:
577
Cov.:
32
AF XY:
0.0769
AC XY:
5722
AN XY:
74394
show subpopulations
African (AFR)
AF:
0.0378
AC:
1572
AN:
41552
American (AMR)
AF:
0.0791
AC:
1210
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0948
AC:
329
AN:
3470
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5174
South Asian (SAS)
AF:
0.0127
AC:
61
AN:
4812
European-Finnish (FIN)
AF:
0.113
AC:
1199
AN:
10590
Middle Eastern (MID)
AF:
0.0850
AC:
25
AN:
294
European-Non Finnish (NFE)
AF:
0.105
AC:
7126
AN:
67988
Other (OTH)
AF:
0.0851
AC:
180
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
545
1091
1636
2182
2727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
134
268
402
536
670
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0911
Hom.:
536
Bravo
AF:
0.0758
Asia WGS
AF:
0.0100
AC:
36
AN:
3478
EpiCase
AF:
0.110
EpiControl
AF:
0.106

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.82
CADD
Benign
0.68
DANN
Benign
0.57
PhyloP100
-1.1
Mutation Taster
=99/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs45598436; hg19: chr1-65335062; COSMIC: COSV61087391; COSMIC: COSV61087391; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.